MACROPHAGE ACTIVATION SYNDROME
Clinical trials for MACROPHAGE ACTIVATION SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MACROPHAGE ACTIVATION SYNDROME trials appear
Sign up with your email to follow new studies for MACROPHAGE ACTIVATION SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to calm dangerous immune storms in Still's and lupus patients
Disease control CompletedThis study tested a drug called emapalumab in 33 children and adults with macrophage activation syndrome (MAS), a life-threatening immune overreaction, linked to Still's disease or lupus. The goal was to see if the drug could safely control the condition and reduce the need for h…
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: PHASE3 • Sponsor: Swedish Orphan Biovitrum • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Small study aims to unlock immune chaos in sepsis patients
Knowledge-focused CompletedThis study looked at 27 adults in intensive care to understand the inflammatory profile of macrophage activation syndrome caused by bacterial sepsis. Researchers measured specific immune markers in blood samples taken over five days. The goal is to gather knowledge that could lea…
Matched conditions: MACROPHAGE ACTIVATION SYNDROME
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC